Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tatsuo Kanda"'
Autor:
Yutaka Midorikawa, Tadatoshi Takayama, Hisashi Nakayama, Tokio Higaki, Masamichi Moriguchi, Kyoji Moriya, Tatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Prior hepatitis B virus infection (PBI) may increase the risk of developing hepatocellular carcinoma (HCC), but the impact of PBI on clinical outcomes following treatment for HCC remains unknown. The aim of this study was to clari
Externí odkaz:
https://doaj.org/article/b557d7695cce46f680249677bc49503a
Autor:
Shunichi Matsuoka, Tadatoshi Takayama, Masamichi Moriguchi, Mitsuhiko Moriyama, Kyoji Moriya, Hisashi Nakayama, Yutaka Midorikawa, Tokio Higaki, Tatsuo Kanda
Publikováno v:
BMC Gastroenterology
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-8 (2019)
Background Prior hepatitis B virus infection (PBI) may increase the risk of developing hepatocellular carcinoma (HCC), but the impact of PBI on clinical outcomes following treatment for HCC remains unknown. The aim of this study was to clarify whethe
Autor:
Yuki Ohta1, Tatsuo Kanda1 kandat-cib@umin.ac.jp, Tatsuro Katsuno1, Shin Yasui1, Yuki Haga1, Reina Sasaki1, Masato Nakamura1, Shuang Wu1, Shingo Nakamoto2, Makoto Arai1, Osamu Yokosuka1, Ohta, Yuki3 (AUTHOR), Kanda, Tatsuo3 (AUTHOR), Katsuno, Tatsuro3 (AUTHOR), Yasui, Shin3 (AUTHOR), Haga, Yuki3 (AUTHOR), Sasaki, Reina3 (AUTHOR), Nakamura, Masato3 (AUTHOR), Wu, Shuang3 (AUTHOR), Nakamoto, Shingo4 (AUTHOR)
Publikováno v:
BMC Gastroenterology. 7/11/2016, Vol. 16, p1-4. 4p. 1 Chart, 1 Graph.
Autor:
Reina Sasaki, Tatsuo Kanda, Shuang Wu, Shingo Nakamoto, Yuki Ohta, Masato Nakamura, Shin Yasui, Yuki Haga, Osamu Yokosuka, Makoto Arai, Tatsuro Katsuno
Publikováno v:
BMC Gastroenterology
Background Ulcerative colitis is a lifelong, immunologically mediated disease. Direct-acting antivirals (DAAs) are now available for the treatment of chronic hepatitis C virus (HCV) infection. An interferon-free regimen appears useful, safe and effec